0 items USD 0.00Search
Your search for "globaldata wet neovascular exudative macular degeneration global clinical trials review h2 2015" gave back 453826 results.
Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Aflibercept is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It is an inhibitor of vascular endothelial...
Catalog:
MRRPB5
August 2024
Price: USD 2,900.00
The global Retinal Biologics market size was valued at US$ million in 2023. With growing demand in downstream market, the Retinal Biologics is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Retinal Disorders Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Retinal Disorders...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Indirect Ophthalmoscope market size was valued at US$ 209.3 million in 2023. With growing demand in downstream market, the Indirect...
Catalog:
LPI
February 2024
Price: USD 3,660.00
A Macular Pucker is an additional layer of tissue or scar tissue that has built on the eye’s central portion of the retina, called macula. Any damage...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Retinal Drugs and Biologics market size was valued at US$ million in 2023. With growing demand in downstream market, the Retinal Drugs and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus...
Catalog:
GIR
August 2024
Price: USD 3,480.00
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Retinal disorders therapy includes medical interventions and treatments used to manage various retinal disorders, such as age-related macular...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Brolucizumab is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). The most...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Macular edema is the accumulation of fluid in the macular retina or under the retina. Macular edema is an important cause of vision loss.Diabetic...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Intravitreal Injectable market size was valued at US$ 14210 million in 2023. With growing demand in downstream market, the Intravitreal...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic...
Catalog:
GIR
August 2024
Price: USD 3,480.00
